| Literature DB >> 33329065 |
Gurjot Kaur1, Anshuman Gaurav1, Thomas Lamb2, Melanie Perkins2, Thivanka Muthumalage2, Irfan Rahman2.
Abstract
Electronic nicotine delivery systems/devices (ENDS) such as electronic cigarettes (e-cigarettes) have been made available globally, with the intent to reduce tobacco smoking. To make these products more appealing to young adults, many brands have added flavoring agents. However, these flavoring agents are shown to progressively result in lung toxicity when inhaled via e-cigarettes. While recent federal regulations have banned the sale of flavored e-cigarettes other than tobacco or menthol flavors, concerns have been raised about the health effects of even these flavors. In this review, we evaluate the current toxicological data with regard to effects upon exposure in animal models and in vitro cell culture for these popular flavorants. We have tabulated the current e-cigarette products containing these most common flavors (menthol, mint, and tobacco) in the market. We have also indicated the prevalence of tobacco and menthol-flavor use among e-cigarette users and highlighted the possible challenges and benefits that will result from new federal regulations.Entities:
Keywords: e-cigarettes; menthol; mint; tobacco; toxicity
Year: 2020 PMID: 33329065 PMCID: PMC7710937 DOI: 10.3389/fphys.2020.613948
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Current literature on mouse inhalation toxicology after flavorant exposure.
| Aerosol | Tobacco and menthol (concentration not mentioned) and other flavors. | 8 weeks old C57BL/6J mice, whole-body inhalation exposure to e-cigarette aerosol (16 mg nicotine), 5 h/day for 3 successive days. For control, mice were exposed to air. | |
| Aerosol | Tobacco flavor (concentration not mentioned) | 8–9 weeks old pregnant C57BL/6 mice, whole-body inhalation exposure to aerosol (without or with nicotine 13 mg/ml). Mice were exposed for 3 h/day, 5 days/week from pregnant to gestation (about 3 weeks). For control, mice were exposed to filtered air. | |
| Aerosol | Tobacco flavor (concentration not mentioned) | Female Balb/c mice were exposed to e-vapor (without or with nicotine 18 mg/ml) twice daily for 6 weeks prior to mating until pups weaned. For control, mice were exposed to room air. | |
| Aerosol | Tobacco blend flavor (4%) | Eight-to-twelve- week-old male C57BL/6 were exposed to e-cigarette aerosol (base with nicotine 18 mg/ml) 4 times a day with 30-min smoke-free intervals for 3 days or 4 weeks. For control mice were exposed to air. |
Current literature on in vitro inhalation toxicology after flavorant exposure.
| E-Liquid | Menthol (10 μg/ml), Hazelnut, Lime flavors | Human periodontal ligament fibroblasts (HPdLF) were incubated up to 96 h with the different liquids (base with nicotine concentration-10μg/ml). For control, fibroblasts were treated with PBS. Cell viability was measured. | |
| Aerosol | Tobacco and menthol (conc. not mentioned) and other flavors. | Human bronchial airway epithelial cells (H292) and human fetal lung fibroblasts (HFL1) treated with various flavored e-liquids for 24 h and examined for morphological changes/cell stress. | |
| Aerosol | Classic tobacco, red American tobacco flavors (concentration not measured in the study) | Normal epithelial cells (HaCaT) and head and neck squamous carcinoma cell line (UMSCC10B, HN30) treated with nicotine free and nicotine containing e-cigarette vapor (base with nicotine concentration 0–12 mg/ml) from 48 h to 8 weeks. Cytotoxicity and Genotoxicity was assessed. | |
| Aerosol | Tobacco, Menthol, (concentration not measured in the study) and other flavors - Pina colada, Coffee and Strawberry | H292 human bronchial epithelial cells exposed to 55 puffs ENDS (base with nicotine content 24 mg/ml). For control, cells were exposed to air using air-liquid interface system. Cell viability, metabolic activity and inflammatory mediators were assessed. | |
| Aerosol | Classic tobacco, Magnificent menthol flavors (concentration not measured in the study) | Human periodontal ligament fibroblasts and human gingival epithelium progenitors pooled exposed to aerosol (nicotine content in classic tobacco and magnificent menthol were ‘16’ mg and ‘0’mg). For control cells were exposed to air. Oxyblots was used to determine protein carbonylation. IL-8 and PGE2 were determined by ELISA. | |
| Aerosol | Tobacco, Mint, and Cinnamon flavors (concentration of Menthol 5–10%, Cinnamon 1.5%) | Cultured human lung adenocarcinoma cells A549 and NCI-H441 exposed to e-cig vapor (base with nicotine 0–18 mg). MTT assay and Alamar Blue tests were performed to analyse cell viability. Pro-inflammatory cytokines release and alveolar-blood barrier integrity were assessed. | |
| Aerosol | Mint, Menthol and other flavors- Cherry, Crisp mint, Vanilla, Apple, Strawberry flavors (concentration not measured in the study) | Human-derived bronchial epithelial cell lines, BEAS-2B, IB3-1, C38 and CALU-3 and human derived fibroblast cell Line-Wi-38, exposed to vapor extract of e liquid (base with nicotine content: 0.8–16 mg/ml) for 24 h. Viability was assessed by using a standard XTT assay. | |
| Aerosol | Vanilla tobacco, Menthol tobacco variant, Solid menthol and other flavors-Captain black cigar, Peanut Butter cookie, T-bone, Popcorn, Black licorice, Energon, Banana pudding, Kola, Hot cinnamon candies (concentration not measured in the study) | Lung epithelial cell line (CALU3) exposed to 13 different flavored e-liquids (base with nicotine content 12 mg/ml). Cell proliferation/viability tested using MTT assay. Measurement were recorded after 24 h. | |
| Aerosol | Tobacco flavors (concentration not measured in the study) | Alveolar type II epithelial cell line (A549) and bronchial epithelial cell line (BEAS-2B) were exposed to e cig vapor (nicotine- 24 mg/ml). Lactate dehydrogenase release was measured to assess cell membrane integrity. | |
| Aerosol | Tobacco, Mint and other flavors-Chocolate, Vanilla, Caramel, Coffee etc. (concentration not measured in the study) | Human pulmonary fibroblasts, lung epithelial cells (A549) and human embryonic stem cells were used in this | |
| Aerosol | Menthol and other flavors: Vanilla, Cinnamon, Strawberry Butter, Banana, Spicy, burnt (concentration not measured in the study) | Endothelial cells were exposed to aerosol. For controls vehicles were matched to flavoring. Cell death, ROS production, expression of the pro-inflammatory interleukin-6, and nitric oxide production were measured. | |
| E-liquid | Tobacco, menthol and other flavors- Alcohol, Berry, Cake, Candy, Coffee/Tea, Fruit flavors (concentration not measured in the study) | Monocytic cells from human pleural tissue (U937) and human monocyte macrophage cell line Monomac-6 (MM6) treated with e-liquid. Cell viability, free ROS and inflammatory cytokines were measured. | |
| E-liquid | Menthol and other flavors- Mango, Watermelon, Cinnamon, Apple, Coffee (concentration not measured in the study) | Human MG-63 and Saos-2 osteoblast-like cells were treated with e-liquid (nicotine content 24 mg/ml) for 48 h. Key osteoblast markers, RUNX2 and Col1al, changes in cell viability were assessed. | |
| E-liquid/Aerosol | Menthol and Tobacco flavors (concentration 1%) | Neural stem cells exposed to e-liquid/aerosol (e-liquids had 44 mg/mL nicotine, whereas aerosols had nicotine of 110 μg/mL). Mitochondrial superoxide levels, mitochondrial protein oxidation, mitochondrial membrane potential, mitochondrial nucleoids and mtDNA damage were measured. | |
| E-liquid | Menthol (0.004-4769.326 μg/g) in Tobacco and other flavors- Vapes Lab Sweet Tobacco Sour Straws, Honey Crème, Vanilla Custard, Coffee crème, Banana ice, Turkish, Craze shake, Double apple, Gemini, Fruitz, HYDRA, Chai Karak, Rainbow grape, Irish, Pineapple, chocolate, Bedrock, Kiberry Yogurt, Milk & Strawberry Wonder, and derived flavors | Human lymphoblastoid TK6 and Chinese hamster ovary cells treated with a total of 68 e-liquid representing 33 brands with nicotine content up to 8 mg. Menthol concentrations were measured in all flavor variants. PAEs, DL-menthol, nicotine, DNA damage, chromosome breakage, and cell viability were assessed. | |
| E-liquid | Tobacco, menthol flavors (concentration not measured in the study although e-liquid tested concentrations are listed) | HMEECs (human middle ear epithelial cells) exposed to flavored e-liquid for 24 hours at various concentrations (0.01 to 10%). Control group were not exposed to e-liquid. | |
| autophagosome marker followed by cell death. Tobacco flavored e-liquid increased the level of inflammatory cytokine and mucin production. Flavored e-liquid induced apoptosis and autophagy reactions. | |||
| Pods | Menthol, Tobacco (individual chemical concentrations were measured in the study) | Beas2b cells (lung epithelial cells) exposed to e-cigarette pods with nicotine concentration of 5% for 22 minutes. For control cells were exposed to air. Puff volume was 55 ml/min. Cells were kept for 8 min to gain exposure of 30 min. |
FIGURE 1Cellular mechanisms of toxicity for menthol and tobacco flavors. The figure summarizes the current cellular pathways and pathogenesis mechanisms involved in cellular toxicity for menthol and tobacco flavorings.
FIGURE 2Cellular dysfunction by inhaled flavoring agents. Flavoring chemicals induced oxidative stress and inflammatory responses are associated with immune-responses via alterations in barrier tight junction dysfunction in the lung. Mitochondrial dysfunction and other cellular alterations can lead to susceptibility to infections. Tobacco flavor (nicotine) activate Nicotinic acetylcholine receptors (nAChRs) and menthol activate cold and menthol receptor 1 (i.e. via TRPM8) leading to various downstream cellular signaling events.
Current literature on flavor induced inhalation toxicology.
| Aerosol | Menthol flavor (concentration not measured in the study) | 8-week-old C57BL/6 mice whole-body inhalation exposure to aerosol (1.8% nicotine), 1.5 h every time, twice/day for 2 weeks. For control mice were exposed to filtered air. | |
| E-liquid | 1–5% Tobacco flavor | Male Wistar rats (160 ± 20 g), Intraperitoneal injection e-liquid (without or with nicotine 18 mg/ml), 0.5 mg/kg of body weight, once/day for 4 weeks. For control mice were treated with physiological saline (500 ml) intraperitonially. | |
| E-liquid | 1–5% Tobacco flavor | Adult Wistar rats (160 ± 20 g), Intraperitoneal injection e-liquid (without or with nicotine- 18 mg/ml), 0.5 mg/kg of body weight, once/day for 4 weeks. For control mice were treated with physiological saline (500 ml) intraperitonially. | |
| Aerosol | Classic tobacco flavor (concentration not measured in the study) | 9-weeks-old pregnant C57BL/6 mice exposed to e-cig aerosol (without or with nicotine 13–16 mg/mL), 3 h/day, 5 days/week from pregnant to gestation (about 3 weeks), continued exposure from postnatal days to lactation. For control mice were exposed to filtered air. | |
| Aerosol | Tobacco flavor (concentration not measured in the study) | Between the ages of 4 and 12 weeks, female BALB/c mice were exposed to one of four e-cigarette aerosols (nicotine 12 mg/ml). Mice were exposed for 1 h/day, 5 days/week up to week 10 of life. From week 11 to 12 of life exposures were increased to 1 h, twice daily, 5 days/week. Twelve mice were exposed to each exposure regime. For control mice were exposed to medical air. | |
| Aerosol | Classic tobacco flavor (concentration not measured in the study) | 6-week-old male (180–200 g) Sprague Dawley rats exposed to e cig vapor (nicotine content 12 mg/ml medium exposure and 24 mg/ml high exposure) for 4 weeks. At 5th week, flap survival was evaluated. For control mice were exposed to room air. | |
| E-liquid | 1–5 % Tobacco flavor | Male Wistar rats (160 ± 20 g), Intraperitoneal injection e-liquid (nicotine concentration-18 mg/ml) for 4 weeks. For Control rats were given i.p. injection of NaCl in a 9 g/l concentration. | |
| Aerosol | Menthol flavor (concentration not measured in the study) | C57BL/6 10J male mice (10 weeks old) exposed to e cig vapor (nicotine concentration- 18 mg/ml) over 2 sessions, i.e., 200 puffs per day, and lasted for 5 days/1 week. For control mice were exposed to clean air. | |
| Aerosol | Tobacco flavor (concentration not measured in the study) | Apo lipoprotein E knockout (ApoE-/-) mice were exposed to e cig aerosol (without nicotine or with 2.4% nicotine) for 12 weeks. DNA damage and mitochondrial dysfunction were assessed. For control mice were exposed to saline aerosol. | |
| Aerosol | Tobacco flavor (concentration not measured in the study) | 24 female Balb/C mice (7 weeks old) and animals were divided into three treatment group and exposed to e-cigarette aerosols (18 mg nicotine). At 12 weeks old offspring’s behavioral assessments were performed. From offspring at P1 (birth), P20 (weaning), and Week 13 brain tissue and plasma were collected. For control mice were exposed to air. | |
| Aerosol | Tobacco flavor (concentration not measured in the study) | Female Balb/C mice (7 weeks old) were exposed to e-cig vapor generated from e-liquid (nicotine concentration- 18 mg/ml) for 6 weeks prior to mating until pups weaned. For control mice were exposed to room air. | |
| Aerosol | Menthol flavor (concentration not measured in the study) | 10 to 12 weeks old C57BL/6J mice were exposed aerosol of e-cigarette pods (concentration of 5% by weight). Mice were exposed to 70 puffs daily for 2 weeks with 3 s puff duration and 25 s of interval time. For control mice were exposed to clean air. | |
| E-liquid | Tobacco flavor (concentration not measured in the study but tested e-liquid concentrations are given) | Human tracheobronchial epithelial cells isolated from bronchi and trachea. Tracheas and bronchi were digested with ice-cold DMEM (0.2% protease). Cells were treated with e-liquid (without nicotine or with nicotine 18 mg/ml) for 48 h. Toxicity was assessed by measuring lactate dehydrogenase (LDH) levels and IL-6 protein levels by ELISA. For control cells were infected with HRV-16 at PBS (control) for 24 h. | |
| Aerosol | Tobacco, Menthol flavors (concentration not measured in the study) | Human umbilical vein endothelial cells (HUVECs) exposed to hydrophilic fraction of e-cigarette vapor (base with nicotine content 6–24 mg/ml). Cell death induction, occurrence of intracellular reactive oxygen species, proliferation rates, and cell morphology were analyzed. | |
| Aerosol | Tobacco flavor (concentration not measured in the study) | E-cig aerosols (nicotine content 16 mg/ml) containing copper nanoparticles exposed to human lung fibroblasts (HFL-1) using an air-liquid interface culture system. For control fibroblasts were exposed to air. | |
| Cartridge | 1–5 % Tobacco flavor | This was laboratory based experimental vs. control group study. Thirty participants participated in this study (experimental group, | |
| Aerosol | Tobacco, strawberry flavor (concentration not measured in the study) | Total of 39 healthy non-smoker participants between the ages of 21 and 45 years. Fifteen subjects used the Green smoke cigalike device with tobacco flavored liquid with 1.2% nicotine. Eighteen subjects used a more efficient second-generation pen like device with strawberry flavoring with 1.2% nicotine. For control, users were asked for puffing without e-liquid. | |
| E-liquid | Tobacco flavor (concentration measured through GC/MS in the study) | A cross over study between tobacco cigarette users and e-cigarette users. Twenty healthy male smokers (before and after e-cig usage) were exposed to e-liquid (base with average nicotine concentration 17.27 mg/ml). Blood pressure, heart rate microvascular reactivity, reactive hyperaemia index, augmentation index and respiratory functions were assessed. | |